Authors: Schenkein, DP Koc, Y Alcindor, T Stadtmauer, EA Miller, KB Cooper, BW Partridge, AH Lazarus, HM

Citation: Dp. Schenkein et al., Treatment of primary resistant or relapsed multiple myeloma with high-dosechemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor, BIOL BLOOD, 6(4A), 2000, pp. 448-455

Authors: Miller, K Schenkein, D Jabro, G Koc, Y Boyle, T Ravalese, J Wazer, D

Citation: K. Miller et al., Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation - Response, BIOL BLOOD, 6(2A), 2000, pp. 213-213

Authors: Koc, Y Miller, KB Schenkein, DP Griffith, J Akhtar, M DesJardin, J Snydman, DR

Citation: Y. Koc et al., Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcome, BIOL BLOOD, 6(1), 2000, pp. 44-49

Authors: Engels, EA Ellis, CA Supran, SE Schmid, CH Barza, M Schenkein, DP Koc, Y Miller, KB Wong, JB

Citation: Ea. Engels et al., Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk, CLIN INF D, 28(2), 1999, pp. 256-266

Authors: Koc, Y Miller, KB Schenkein, DP Daoust, P Sprague, K Berkman, E

Citation: Y. Koc et al., Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation, CANCER, 85(3), 1999, pp. 608-615

Authors: Koc, Y Schenkein, DP

Citation: Y. Koc et Dp. Schenkein, Therapy of diffuse aggressive lymphomas, CANC TREAT, 99, 1999, pp. 47-73